Establishment of a congenital chloride diarrhea-associated SLC26A3 c.392C>G (p.P131R) polymorphism-expressing cell model and a preliminary analysis of its mechanism of action
ZHANG Ni-Ni, GUO Hong-Wei, LIN Yan, ZHANG Wei, ZHANG Wei, WANG Bao-Xi, JIANG Xun
Department of Pediatrics, Tangdu Hospital, Air Force Military Medical University/The Fourth Military Medical University, Xi'an 710038, China
Abstract Objective To establish a congenital chloride diarrhea (CCD)-associated SLC26A3 c.392C > G (p.P131R) polymorphism-expressing cell model, and to investigate its biological function. Methods The sequence of the SLC26A3 gene in GenBank was used to design the upstream and downstream single-guide RNA (sgRNA) that could specifically recognize the 392 locus of the SLC26A3 gene, and the sgRNA was mixed with the pSpCas9-puro vector after enzyme digestion to construct an eukaryotic recombinant expression plasmid (pSpCas9-SLC26A3). Caco-2 cells were transfected with the recombinant plasmid and synthesized single-stranded DNA oligonucleotides (ssODNs), and Taqman genotyping assay and Sanger sequencing were used to identify the expression of SLC26A3 c.392C > G (p.P131R) in Caco-2 cells. Wild-type Caco-2 cells were selected as normal control group and the Caco-2 cells with successful expression of SLC26A3 c.392C > G (p.P131R) was selected as P131R group. Both groups were treated with 100 ng/mL tumor necrosis factor-α (TNF-α), and then the normal control group was named as TNF-α group, and the P131R group was named as TNF-α+P131R group. Electric cell-substrate impedance sensing (ECIS) assay was used to evaluate the change in the monolayer barrier function of intestinal epithelial cells in the above four groups, and Western blot was used to measure the change in the expression of SLC26A3 protein in the normal control group and the P131R group. Results The eukaryotic recombinant expression plasmid (pSpCas9-SLC26A3) was successfully constructed. Both Taqman genotyping assay and Sanger sequencing confirmed the successful establishment of the Caco-2 cell model of SLC26A3 c.392C > G (p.P131R) expression. ECIS assay showed that compared with the normal control group, the P131R group had a significant increase in the monolayer permeability of intestinal epithelial cells (P P P=0.001). Conclusions SLC26A3 c.392C > G (p.P131R) can reduce the expression of SLC26A3 protein, increase the monolayer permeability of intestinal epithelial cells, and thus lead to diarrhea.
ZHANG Ni-Ni,GUO Hong-Wei,LIN Yan et al. Establishment of a congenital chloride diarrhea-associated SLC26A3 c.392C>G (p.P131R) polymorphism-expressing cell model and a preliminary analysis of its mechanism of action[J]. CJCP, 2019, 21(11): 1131-1137.
ZHANG Ni-Ni,GUO Hong-Wei,LIN Yan et al. Establishment of a congenital chloride diarrhea-associated SLC26A3 c.392C>G (p.P131R) polymorphism-expressing cell model and a preliminary analysis of its mechanism of action[J]. CJCP, 2019, 21(11): 1131-1137.
Jiang F, Doudna JA. CRISPR-Cas9 structures and mechanisms[J]. Ann Rev of Biophys, 2017, 46(1):505-529.
[2]
Erdmann V, Barciszewski J, From nucleic acids sequences to molecular medicine[M]. Berlin:Springer, 2012:121-143.
[3]
Ran FA, Hsu PD, Wright J, et al. Genome engineering using the CRISPR-Cas9 system[J]. Nat Protoc, 2013, 8(11):2281-2308.
[4]
Zhang W, He T, Wang Q, et al. Interleukin-1 receptor-associated kinase-2 genetic variant rs708035 increases NF-κB activity through promoting TRAF6 ubiquitination[J]. J Biol Chem, 2014, 289(18):12507-12519.
[5]
Heruth DP, Katherine S, Nini Z, et al. Genetic association of single nucleotide polymorphisms with acetaminophen-induced hepatotoxicity[J]. J Pharmacol Exp Ther, 2018, 367(1):95-100.
[6]
Katherine S, Heruth DP, Nini Z, et al. Identification of novel regulatory genes in APAP induced hepatocyte toxicity by a genome-wide CRISPR-Cas9 screen[J]. Sci Rep, 2019, 9(1):1396.
[7]
Matsunoshita N, Nozu K, Yoshikane M, et al. Congenital chloride diarrhea needs to be distinguished from Bartter and Gitelman syndrome[J]. J Hum Genet, 2018, 1(63):887-892.
[8]
Chatterjee I, Kumar A, Castilla-Madrigal RM, et al. CDX2 upregulates SLC26A3 gene expression in intestinal epithelial cells[J]. Am J Physiol Gastrointest Liver Physiol, 2017, 313(3):G256-G264.
[9]
Asano K, Matsushita T, Umeno J, et al. A genome-wide association study identifies three new susceptibility loci for ulcerative colitis in the Japanese population[J]. Nat Genet, 2009, 41(12):1325-1329.
[10]
Wedenoja S, Pekansaari E, Höglund P, et al. Update on SLC26A3 mutations in congenital chloride diarrhea[J]. Hum Mutat, 2011, 32(7):715-722.
[11]
Freedman JC, Hendricks MR, McClane BA, et al. The potential therapeutic agent mepacrine protects Caco-2 cells against Clostridium perfringens enterotoxin action[J]. mSphere, 2017, 2(4). pii:e00352-17.
[12]
Cong L, Ran FA, Cox D, et al. Multiplex genome engineering using CRISPR/Cas systems[J]. Science, 2013, 339(6121):819-823.
[13]
Katherine S, Suman C, Dmitry G, et al. Identification of novel single nucleotide polymorphisms associated with acute respiratory distress syndrome by exome-seq[J]. PLoS One, 2014, 9(11):e111953.
[14]
Kho DT, Johnson RH, O'Carroll SJ, et al. Biosensor technology reveals the disruption of the endothelial barrier function and the subsequent death of blood brain barrier endothelial cells to sodium azide and its gaseous products[J]. Biosensors (Basel), 2017, 7(4). pii:E41.
[15]
Ding X, Li D, Li M, et al. SLC26A3(DRA) prevents TNFalpha-induced barrier dysfunction and dextran sulfate sodiuminduced acute colitis[J]. Lab Invest, 2018, 98(4):462-476.
[16]
Ding Y, Li H, Chen LL, et al. Recent advances in genome editing using CRISPR/Cas9[J]. Front Plant Sci, 2016, 7:703.
[17]
Bernheim A, Calvo-Villamañán A, Basier C, et al. Inhibition of NHEJ repair by type II-A CRISPR-Cas systems in bacteria[J]. Nat Commun, 2017, 8(1):2094.
[18]
Komor AC, Kim YB, Packer MS, et al. Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage[J]. Nature, 2016, 533(7603):420-424.
[19]
Bhardwaj S, Pandit D, Sinha A, et al. Congenital chloride diarrhea-novel mutation in SLC26A3 gene[J]. Indian J Pediatr, 2016, 83(8):859-861.
[20]
Thiagarajah JR, Kamin DS, Acra S, et al. Advances in evaluation of chronic diarrhea in infants[J]. Gastroenterology, 2018, 154(8):2045-2059.
Shao XX, Lin DP, Sun L, et al. Association of ulcerative colitis with solute-linked carrier family 26 member A3 gene polymorphisms and its expression in colonic tissues in Chinese patients[J]. Int J Colorectal Dis, 2018, 33(9):1169-1172.
